Surging diabetes rate underscores vast opportunity in weight-loss drugs
The number of adults diagnosed with diabetes has more than quadrupled since 1990 and now stands above 800 million, according ...
Is Ozempic the modern wonder drug? All the conditions the weight loss jab can tackle — from addiction to Alzheimer’s
Even if you you’re not diabetic or obese, can Ozempic be right for you? Ever since the weekly injectable was approved in 2017 ...
New weight loss drug decreases appetite without nausea — and can even burn calories
Scientists from the University of Copenhagen say they have developed a drug that decreases appetite while increasing calorie ...
cnbctv1814h
World Diabetes Day | Can new drugs, innovative treatments offer better management of disease
New classes of drugs like the SGLT-2 Inhibitors and GLP-1 Receptor Agonists  have tremendous potential for managing the blood ...
WebMD2d
New Guidance for Patients Taking GLP-1 Drugs Before Surgery
As the FDA issues a new warning about aspiration across all GLP-1 weight loss drugs, doctor groups are giving new ...
McKnight's Long-Term Care News3d
New diabetes practice guideline designed for LTC providers
Diabetes is very common in people living in post-acute and long-term environments, affecting 25% to 34% of these individuals.
Healthline10d
Ozempic vs. Victoza: Which Is Better for Me?
In addition, the American Diabetes Association’s treatment guidelines recommend GLP-1 agonists (the drug class Ozempic and Victoza belong to) as a treatment option for adults with type 2 ...
Knowridge11d
This drug show promise for protecting kidneys, heart, and lungs in diabetes
Sodium-glucose cotransporter 2 inhibitors (SGLT2 inhibitors) are a relatively new group of medications originally developed ...
EurekAlert!4d
GLP-1, SGLT2 medications may lower stroke survivor’s risk of future heart attack, stroke
Embargoed until 4 a.m. CT/5 a.m. ET, Monday, Nov. 11, 2024 DALLAS, Nov. 11, 2024 — GLP-1 receptor agonists and SGLT2 inhibitors, two classes of medications most commonly prescribed to treat Type 2 ...
Warwick Advertiser11d
Crystal Run offering virtual diabetes management classes
Crystal Run Healthcare’s diabetes self-management Zoom classes, scheduled from 11 a.m. to 12:30 p.m. on Nov. 12 and Dec. 3, ...
French Biotech Company AdipoPharma Secures Funding to Initiate Clinical Trials for its first-in-class compound for Insulin Resistance
Dr. Marion has assembled a team of high-profile, experienced pharmaceutical executives, former senior FDA members, and academic scientists to lead the development of PATAS. He has also established ...